However, in the exenatide treatment group, the primary outcome rate was 61.2% (n=170), compared to 56.7% in the standard treatment group (n=171), with an adjusted ratio of 1.22 [95% CI, 0.79-1.88] (P=0.38)., which meant that the proportion of subjects who achieved the desired effect in exenatide treatment group was higher (110)
Cognitive Function: This delicious multivitamin blend includes key nutrients pantothenic acid, biotin, niacin, and vitamin B12 to support brain function
Oleo Sci
#mitochondria #bioenergetics #neuropsychiatry To view or add a comment, sign in Could GLP-1based therapies have a future role in migraine management
One consequence of this popularity is that despite their high cost, the GLP-1 agonist medications have seen demand outstrip their supply resulting in shortages making their availability to treat diabetes more limited